These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4760541)

  • 1. Oncogenic purine N-oxide derivatives as substrates for sulfotransferase.
    McDonald JJ; Stöhrer G; Brown GB
    Cancer Res; 1973 Dec; 33(12):3319-23. PubMed ID: 4760541
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative reactivities of esters of oncogenic and nononcogenic purine N-oxides and evidence of the oxidation-reduction reactivity of aromatic nitrenium ions.
    Parham JC; Templeton MA
    Cancer Res; 1980 May; 40(5):1475-81. PubMed ID: 7370985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulfotransferase.
    Morton KC; Beland FA; Evans FE; Fullerton NF; Kadlubar FF
    Cancer Res; 1980 Mar; 40(3):751-7. PubMed ID: 6937241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of derivatives of the oncogenic purine N-oxides.
    McCuen RW; Stöhrer G; Sirotnak FM
    Cancer Res; 1974 Feb; 34(2):378-84. PubMed ID: 4204232
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidizing action of purine N-oxide esters.
    Stöhrer G; Salemnick G
    Cancer Res; 1975 Jan; 35(1):122-31. PubMed ID: 234029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine N-oxides. XXVII. The metabolism of guanine 3-oxide by the rat.
    Stöhrer G; Brown GB
    J Biol Chem; 1969 May; 244(9):2494-7. PubMed ID: 5783843
    [No Abstract]   [Full Text] [Related]  

  • 8. Species differences of glucuronidation and sulfation in relation to hepatocarcinogenesis.
    Bock KW; Schirmer G
    Arch Toxicol Suppl; 1987; 10():125-35. PubMed ID: 3107520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in cell proliferation and N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration.
    Jackson CD; Irving CC
    Cancer Res; 1972 Jul; 32(7):1590-4. PubMed ID: 5030584
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of purine N-oxides and effect of selected compounds on tumors induced by purine N-oxides.
    Sugiura K
    Cancer Chemother Rep 2; 1968 Nov; 1(2):383-402. PubMed ID: 5732304
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of the oncogenic 1-methylguanine 3-oxide to 3-hydroxy-1-methylxanthine.
    McDonald JJ; Stöhrer G; Brown GB
    Cancer Res; 1976 Oct; 36(10):3604-7. PubMed ID: 953986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of beta-glucuronidase by deficient human fibroblasts.
    Lagunoff D; Nicol DM; Pritzi P
    Lab Invest; 1973 Oct; 29(4):449-53. PubMed ID: 4270349
    [No Abstract]   [Full Text] [Related]  

  • 13. Purine N-oxides. XIX. On the oncogenic N-oxide derivatives of guanine and xanthine and a nononcogenic isomer of xanthine N-oxide.
    Sugiura K; Brown GB
    Cancer Res; 1967 May; 27(5):925-31. PubMed ID: 4290727
    [No Abstract]   [Full Text] [Related]  

  • 14. Purine N-oxides. XVI. Oncogenic derivatives of xanthine and guanine.
    Brown GB; Sugiura K; Cresswell RM
    Cancer Res; 1965 Aug; 25(7):986-91. PubMed ID: 5843273
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfotransferase assays.
    Ramaswamy SG; Jakoby WB
    Methods Enzymol; 1987; 143():201-7. PubMed ID: 3309553
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC; Lang NP; Kadlubar FF
    Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

  • 18. [Formation of bile acid sulfate esters in perfused rat livers following bile duct occlusion].
    Liersch M; Stiehl A
    Z Gastroenterol; 1974 Mar; 12(2):131-4. PubMed ID: 4825092
    [No Abstract]   [Full Text] [Related]  

  • 19. Tests for chemical carcinogens. Report on the activity of derivatives of aromatic amines, nitrosamines, quinolines, nitroalkanes, amides, epoxides, aziridines, and purine antimetabolites.
    Hadidian Z; Fredrickson TN; Weisburger EK; Weisburger JH; Glass RM; Mantel N
    J Natl Cancer Inst; 1968 Oct; 41(4):985-1036. PubMed ID: 5686039
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.